Bing Xiong

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Journal of medicinal chemistry

RSC medicinal chemistry

Shanghai Institute of Materia Medica Chinese Academy of Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Institute of Materia Medica Chinese Academy of Sciences

China

PI :: Medchem

Publications

Xuetao Chen, Danyan Cao, Chihong Liu, Fanying Meng, Zijian Zhang, Rujun Xu, Yuanyuan Tong, Yabing Xin, Weikun Zhang, Wenjing Kang, Qichao Bao, Jingkang Shen, Bing Xiong, Qi-Dong You, Zheng-Yu Jiang
Discovery of 1 H -Imidazo[4,5- b ]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain. Journal of medicinal chemistry (2023)
Lingyu Song, Jiawen Cao, Lin Chen, Zhiyan Du, Naixia Zhang, Danyan Cao, Bing Xiong
Screening and optimization of phage display cyclic peptides against the WDR5 WBM site. RSC medicinal chemistry 14 (10) (2023)
Na Li, Hong Yang, Ke Liu, Liwei Zhou, Yuting Huang, Danyan Cao, Yanlian Li, Yaoliang Sun, Aisong Yu, Zhiyan Du, Feng Yu, Ying Zhang, Bingyang Wang, Meiyu Geng, Jian Li, Bing Xiong, Shilin Xu, Xun Huang, Tongchao Liu
Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors. Journal of medicinal chemistry 65 (13) (2022)
Bowen Yang, Haoran Zhang, Na Li, Lixin Gao, Hong Jiang, Weijuan Kan, Haoxing Yuan, Jia Li, Dongmei Zhao, Bing Xiong, Yubo Zhou, Dong Guo, Tongchao Liu
Discovery of Novel N -(5-(Pyridin-3-yl)-1 H -indazol-3-yl)benzamide Derivatives as Potent Cyclin-Dependent Kinase 7 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease. Journal of medicinal chemistry 65 (23) (2022)
Bing Xiong
Allosteric Modulation: Dynamics is Double-"E"dged. Journal of medicinal chemistry 64 (7) (2021)
Zhuqing Zhang, Zuhao Guo, Xiaowei Xu, Danyan Cao, Hong Yang, Yanlian Li, Qiongyu Shi, Zhiyan Du, Xiaobin Guo, Xin Wang, Danqi Chen, Ying Zhang, Lin Chen, Kaixin Zhou, Jian Li, Meiyu Geng, Xun Huang, Bing Xiong
Structure-Based Discovery of Potent CARM1 Inhibitors for Solid Tumor and Cancer Immunology Therapy. Journal of medicinal chemistry 64 (22) (2021)
Kaikai Lv, Weicong Chen, Danqi Chen, Jie Mou, Huijie Zhang, Tiantian Fan, Yanlian Li, Danyan Cao, Xin Wang, Lin Chen, Jingkang Shen, Dongsheng Pei, Bing Xiong
Rational Design and Evaluation of 6-(Pyrimidin-2-ylamino)-3,4-dihydroquinoxalin-2(1H)-ones as Polypharmacological Inhibitors of BET and Kinases. Journal of medicinal chemistry 63 (17) (2020)
Zuhao Guo, Zhuqing Zhang, Hong Yang, Danyan Cao, Xiaowei Xu, Xingling Zheng, Danqi Chen, Qi Wang, Yanlian Li, Jian Li, Zhiyan Du, Xin Wang, Lin Chen, Jian Ding, Jingkang Shen, Meiyu Geng, Xun Huang, Bing Xiong
Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia. Journal of medicinal chemistry 62 (11) (2019)
Jianping Hu, Chang-Qing Tian, Mohammadali Soleimani Damaneh, Yanlian Li, Danyan Cao, Kaikai Lv, Ting Yu, Tao Meng, Danqi Chen, Xin Wang, Lin Chen, Jian Li, Shan-Shan Song, Xia-Juan Huan, Lihuai Qin, Jingkang Shen, Ying-Qing Wang, Ze-Hong Miao, Bing Xiong
Structure-Based Discovery and Development of a Series of Potent and Selective Bromodomain and Extra-Terminal Protein Inhibitors. Journal of medicinal chemistry 62 (18) (2019)

Bing Xiong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bing Xiong